How do I buy Baxter International (BAX) stock?

Buying Baxter International (BAX) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "BAX", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy BAX by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if BAX is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Baxter International (BAX) Stock

Q: What is the minimum investment for BAX on Gotrade?

On Gotrade , you don't have to buy a full lot. With fractional shares, you can start investing in Baxter International from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · BAX

Trade BAX

Key stats

Market cap: $13.19B
Price / Earnings ratio: -18.2x
EPS (TTM): -$1.42
Volume: Loading
52-week high: $30.00
52-week low: $15.73
Dividend yield: 0.15%
Dividend amount (latest): $0.01
EPS vs analyst estimate: +15.0%Q3 FY25 · $0.69 vs $0.60

Source: third-party data provider, as of November 5, 2026

EPS estimate: analyst consensus

Compare with BAX

Technical indicators

RSI 14: 61.06
MACD 12/26/9: 0.19
EMA 9 of MACD: 0.11
MACD histogram: 0.08
SMA 50: $24.52; Price above SMA 50
EMA 50: $24.53; Price above EMA 50
SMA 200: $21.42; Price above SMA 200
EMA 200: $21.82; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 4, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Hold

Based on 3 analyst ratings

Strong Sell0

Sell0

Hold3

Buy0

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2025

18B12B6B0

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2025

40B27B13B0

Revenue to Profit

2025

$11.2B

Revenue

$0.0

Cost of revenue

$3.4B

Gross profit

$0.0

Operating expenses

$-957.0M

Net income

Earnings

EPS forecast

Actual EPS

$0.69

$0.60

Q3FY25

$0.53

Q4FY25

$0.50

Q1FY26

$0.56

Q2FY26

$0.60

Q3FY26

The market is expecting earnings per share of $0.60 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Baxter International

Our more than 85-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work.

SectorHealthcare

IndustryMedical Instruments & Supplies

Employees37,500

CEOMr. Andrew P. Hider

IPO DateOct 27, 1981

HeadquartersDeerfield, IL

Key Executives

Name	Title	Year Born
Mr. Andrew P. Hider	CEO, Pres., Interim Group Pres. of Medical Products & Therapies and Director	1977
Mr. John Terence Rogers	Executive VP & CFO	1969
Mr. David S. Rosenbloom	Executive VP & General Counsel	1960
Ms. Maria Soriano	Group President of Infusion Therapies & Platforms	—
Mr. Bernie Heine	Interim Chief Accounting Officer & Controller	1986
Mr. Charles Patel	Senior VP & Chief Information Officer	1970
Mr. Kevin Moran	Vice President & Head of Investor Relations	—
Ms. Stacey Eisen	SVP, Chief Communications Officer & Corporate Marketing and President of Baxter Foundation	—
Ms. Cynthia Carlisle	Executive VP & Chief Human Resources Officer	1975
Mr. James W. Borzi	Executive VP & Chief Supply Chain Officer	1963

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-5.3	+14.3
2022	-1.6	+0.0	-7.8	-9.6	+7.7	-13.8	-10.4	-2.1	-5.1	-2.3	+5.2	-2.7
2023	-10.5	-13.7	+3.8	+19.3	-14.1	+10.5	+1.2	-9.8	-7.0	-13.2	+10.0	+5.8
2024	-0.4	+4.4	+4.2	-7.3	-15.5	-1.8	+8.3	+5.4	+0.3	-3.3	-6.0	-13.1
2025	+11.3	+9.1	-1.8	-8.4	-0.6	+2.5	-30.3	+12.4	-5.8	-20.9	+2.9	+0.2
2026	+2.9	+2.5	-14.7	+4.8	+9.1	+15.9	+20.6	-7.5	-5.8	-2.7	+9.4

Stocks in the same sector

FAQ

Buying Baxter International (BAX) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and complete KYC.
Make a deposit.
Search for the code "BAX", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy BAX by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Baxter International from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Yes, Baxter International regularly pays dividends to shareholders. Currently, the estimated dividend yield for BAX is around 0.15% per year. On Gotrade, cash dividends will be automatically credited to your account balance (after taxes).

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB, or 8:30 PM to 3:00 AM WIB during Daylight Saving Time. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.

Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Baxter International (BAX) Stock

Key stats

Compare with BAX

Recent news

What Baxter International (BAX) Said on Its Q3 Earnings Call

What Baxter International (BAX) Said on Its Q3 Earnings Call

Baxter Q3 Earnings Beat on Broad-Based Growth, '26 Outlook Raised

Baxter Q3 Earnings Beat on Broad-Based Growth, '26 Outlook Raised

Compared to Estimates, Baxter (BAX) Q3 Earnings: A Look at Key Metrics

Compared to Estimates, Baxter (BAX) Q3 Earnings: A Look at Key Metrics

Baxter International (BAX) Q3 Earnings and Revenues Surpass Estimates

Baxter International (BAX) Q3 Earnings and Revenues Surpass Estimates

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

What Baxter International (BAX) Said on Its Q3 Earnings Call

What Baxter International (BAX) Said on Its Q3 Earnings Call

Baxter Q3 Earnings Beat on Broad-Based Growth, '26 Outlook Raised

Baxter Q3 Earnings Beat on Broad-Based Growth, '26 Outlook Raised

Compared to Estimates, Baxter (BAX) Q3 Earnings: A Look at Key Metrics

Compared to Estimates, Baxter (BAX) Q3 Earnings: A Look at Key Metrics

Baxter International (BAX) Q3 Earnings and Revenues Surpass Estimates

Baxter International (BAX) Q3 Earnings and Revenues Surpass Estimates

Baxter Reports Third-Quarter 2026 Results

Baxter Reports Third-Quarter 2026 Results

Will Baxter's Q3 Earnings Show Progress Despite Cost Pressures?

Will Baxter's Q3 Earnings Show Progress Despite Cost Pressures?

Analysts Estimate Baxter International (BAX) to Report a Decline in Earnings: What to Look Out for

Analysts Estimate Baxter International (BAX) to Report a Decline in Earnings: What to Look Out for

Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors

Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors

Are Investors Undervaluing Baxter International (BAX) Right Now?

Are Investors Undervaluing Baxter International (BAX) Right Now?

Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?

Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?

About Baxter International

Key Executives

Fundamentals

Valuation

Profitability

Trading

Dividend

Technical indicators

Analyst views

Seasonality

Corporate actions

Upcoming

Past

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade